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Diphtheria toxin fragment A is able to inhibit protein synthesis in the eukaryotic cell by ADP-ribosylating 
the diphthamide residue of elongation factor-2 (EF-2) [(1980) J. Biol. Chem. 255, 10710-107201. The reac- 
tion requires NAD as ADP-ribose donor. This work reports on the capacity of an NAD analog, the nicotin- 
amide I-N4ethenoadenine dinucleotide (ENAD), to be a substrate of diphtheria toxin fragment A in the 
transferring reaction of the fluorescent moiety, the aADP-ribose, to the EF-2. As a consequence of the 
transfer of the EADP-ribosyl moiety to the EF-2, there is an increase in the emission intensity of the fluo- 
rophore and a blue shift in its emission maximum. The sADP-ribosylated EF-2, like ADP-ribosylated EF-2, 
retains the capacity to bind GTP and ribosome. The utility of introducing a fluorescent probe in a well 
defined point of the EF-2 molecule for conformational or binding studies is discussed. 
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1. INTRODUCTION 
The nicotinamide 1-N6-ethenoadenine dinucleo- 
tide (6NAD) is a fluorescent analog of NAD which 
has been shown to be interchangeable with NAD in 
the binding with several dehydrogenases [2,3]. It 
exists in a stacked conformation in solution but 
assumes an open form, which has a much higher 
quantum yield, when bound to the dehydrogenases 
[2-41. Its fluorescence maximum is around 410 nm 
and can be excited above 305 nm, a region where 
the aromatic chromophores of proteins do not in- 
terfere [2-41. 
Diphtheria toxin fragment A transfers the ADP- 
ribose moiety from NAD to an acceptor site on the 
EF-2 molecule, which has been identified as a post- 
translationally modified histidine residue, called 
diphthamide [l]. The ADP-ribosylated EF-2 no 
longer catalyzes the translocation, although it still 
retains the capacity to bind GTP and to form a ter- 
nary complex with ribosomes [5]. 
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Here, we show that diphtheria toxin fragment A 
is able to transfer the fADP-ribose moiety from 
eNAD to the EF-2 molecule. Some fluorescence 
properties of fADP-ribosylated EF-2 are reported. 
Moreover, we examine the behaviour of fADP- 
ribosylated EF-2 in GTP and ribosome binding. 
2. MATERIALS AND METHODS 
2.1. Purification of cNAD 
t_NAD was purchased from P-L Biochemicals 
and purified by high-performance liquid 
chromatography (HPLC), using an Altex Ultrasil- 
Ax column equilibrated with 50 mM formic acid 
and eluted with the same solvent. Concentrations 
of eNAD were determined at pH 7 using a molar 
extinction coefficient of 1.0 x lo3 at 265 nm [3]. 
2.2. Purification of EF-2 and preparation of 
CADP-ribosylated EF-2 
EF-2 was obtained from human placenta by an 
original procedure (in preparation) which, briefly, 
consists in precipitation at pH 5 of the 
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postmitochondrial fraction and sequential chro- 
matographies on DEAE-cellulose, heparin- 
Sepharose and Sephadex G-150 resins. To obtain 
the CADP-ribosylated protein, EF-2 (1 mg/ml) was 
incubated for 60 min at 25°C in the presence of 
fragment A (1 ,ug/ml), purified as in [6], with 
50pM eNAD in a buffer containing 50 mM Tris- 
HCI, pH 7.8, 1 mM EDTA and 5 mM 
dithiothreitol. 
2.3. Reversal of ADP-ribosylation 
The EADP-ribosylated EF-2 (0.5 mg/ml) was in- 
cubated at pH 6.5 in the presence of fragment A 
(10 pg/ml) and nicotinamide (2 mM) at 25°C. The 
reaction products were analyzed by HPLC as in 
section 2.1 after deproteinization with formic acid. 
2.4. Digestion of CADP-ribosylated EF-2 with 
phosphodiesterase 
The CADP-ribosylated EF-2, obtained as 
described in section 2.2, was exhaustively dialyzed 
against the incubation buffer and then chro- 
matographed on a Sephadex G-25 column, 
to eliminate completely the eNAD excess. 
Phosphodiesterase from Crotalus durissus (Boeh- 
ringer, Mannheim) was then added to the protein 
solution to a final concentration of 10 pug/ml. The 
solution was allowed to stand for 30 min at 37°C. 
The reaction products were analyzed as described 
in section 2.1 after deproteinization with formic 
acid. 
2.5. Fluorescence measurements 
Fluorescence spectra and intensities were ob- 
tained with a Perkin-Elmer MPF-44B spec- 
trofluorometer. Fluorescence measurements were 
made in the range where emission was linear with 
eNAD concentration. The absorbance of all solu- 
tions was less than 0.1 at the excitation 
wavelength. The temperature of the solution cells 
was maintained at 25°C. 
3. RESULTS 
Incubation of EF-2 with eNAD in the presence 
of diphtheria toxin fragment A results in a time- 
dependent enhancement of the fluorescence emis- 
sion at 410 nm with a blue shift of the emission 
maximum of about 5 nm. Fig.1 (inset) reports the 
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time course of this reaction under the conditions 
specified in the legend, while curves a and b repre- 
sent the emission spectra of the incubation mix- 
ture, excited at 320 nm, before the addition of 
fragment A and at the end of the reaction. 
It is known that upon binding to proteins, such 
as some dehydrogenases, the fluorescence of 
6NAD increases due to the separation of the 
nicotinamide and ethenoadenine rings which are 
partially stacked in the free molecule [2-41. Ac- 
tually, so far, no reaction in which a moiety of the 
<NAD is transferred has been reported. The 
following experiments demonstrate that, in the 
case of the reaction of EF-2 with cNAD, the 
fluorescence increase has to be ascribed to the 
transfer of the ADP-ribose moiety to the protein. 
In fact, the incubation of eNAD in the presence of 
EF-2, without fragment A, does not result in a 
fluorescence increase. Thereafter we can exclude 
that, if binding occurs, it leads to a quantum yield 
variation of eNAD (as in the case of its binding to 
Wavelength,nm 
Fig.1. Fluorescence emission spectra of the incubation 
mixture before the addition of fragment A (curve a) and 
at the end of the reaction (curve b). Excitation was at 
320 nm. The incubation mixture contained:, EF-2 
(1 mg/ml), eNAD (5 FM), fragment A (1 pg/ml). Inset: 
time course of the reaction monitored by the 
fluorescence emission increase at 410 nm. 
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the dehydrogenase). Thus the observed flu- 
orescence increase, after the addition of fragment 
A, is more likely due to the unstacking of the 
adenine ring from the ui~ot~n~de ring as a conse- 
quence of the transfer of the eADP-ribose moiety 
to EF-2. 
Moreover, after exhaustive dialysis of the in- 
cubation mixture (also cont~ning fragment A), 
against either the incubation buffer or incubation 
buffer plus 4 M guanidine hydrochloride, the 
fluorescence of the dialyzed mixture was retained. 
Another result consistent with the hypothesis of 
a fluorophore covalently bound to the EF-2 was 
also obtained from chromatography of the incuba- 
tion mixture on a Sephadex G-25 column 
equilibrated in 6 M guanidine hydrochloride. Two 
fluorescent peaks emerged from the column: the 
first, containing the protein, in the excluded 
volume, the second, containing the free ENAD, in 
the void volume region. 
Treatment of the incubation mixture with 
phosphodiesterase and successive dialysis against 
the incubation buffer led to the complete loss of 
the fluorescence of the dialyzed mixture. The 
phosphodiesterase is able to cleave the 5 ‘-AMP 
from the ADP-ribosylated EF-2 171. The incuba- 
tion mixture was loaded on a Sephadex G-25 cot- 
umn equilibrated with incubation buffer. The 
front fluorescent peak was treated with 
phosphodiesterase: a substance was produced 
which had the same retention peak in HPLC as 
c 
Fig.2. HPLC elution pattern of: a standard mixture of 
eNAD and 5 ‘-CAMP (a); phosphodiesterase digestion 
products of EADP-ribosylated EF-2 (b); products from 
the reversal of HALF-ribosylation by fragment A and 
nicotinamide (c). Column, Altex Ultrasi Ax, 
0.46-25 cm; eluent, 50 mM formic acid; flow rate, 
1 mllmin. 
5’-eAMP (fig.2b). On the other hand, incubation 
of the front fluorescent peak with fragment A and 
adenosine~U~~4C~NAD does not result in incor- 
poration of radioactivity in the trichloroacetic 
acid”precipitable fraction. 
It is well known that fragment A is able to 
reverse the ADP-ribosylation of EF-2 in the 
presence of nicotinamide, forming NAD and EF-2 
[S], The pH optimum for the reverse reaction is 
lower than that of the forward reaction, Incuba- 
tion of the front fluorescent peak from Sephadex 
G-25 with fragment A and nicotinamide at pH 6.5 
produces a substance which has the same 
~hromatographic behaviour as eNAD in HPLC 
(fig2c). 
4. DISCUSSION 
The ADP-ribosylation reaction catalyzed by 
fragment A is highly specific for eukaryotic EF-2. 
Moreover, it has been proved that EF-2 has a uni- 
que attachment site for ADP-ribose, i.e. 
diphthamide, an amino acid resulting from the 
posttranslational modification of a histidine 
residue [ 1 J. Diphthamide has been found in all ex- 
amined eukaryotic cells 191. As a consequence of 
ADP-ribosylation, EF-2 becomes unable to 
catalyze the translocation although it retains the 
capacity to bind GTP and ribosome in forming the 
ternary complex [S]. Therefore, the possibility of 
specifically binding a fluorescent probe, having 
suitable spectral features, to the diphthamide 
could be of great utility in studying, with the power 
of fluorescence techniques, the molecular district 
of EF-2 containing that crucial residue. The 
I-N6-etheno-ADP-ribosyl moiety does have those 
features. It has, first of all, a high structural 
similarity to the ADP-ribosyl moiety and 
possesses, among spectral aspects, high quantum 
yield, high intrinsic polarizations long lifetime, and 
excitation and emission spectra clearly resolved 
from those of the protein fluorophores [lo]. 
Moreover, CADP-ribosyl labelling of diphthamide 
is achieved with an efficient and selective en- 
zymatic mechanism which assures, besides the 
specificity, the uniqueness of the labelled site on 
the protein. The specificity also allows the use of 
a poorly purified EF-2. 
Our results leave no doubt that ENAD is inter- 
changeable with NAD as a substrate of fragment A 
193 
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in the ADP-ribosylation of EF-2 and in the reverse REFERENCES 
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reaction. At this point the question arises of 
whether fADP-ribosylated EF-2 retains the same 
molecular properties as ADP-ribosylated EF-2. So 
far, we have found that EADP-ribosylated EF-2 
behaves like ADP-ribosylated EF-2 in forming the 
ternary complex with GTP and ribosome. In fact, 
after incubation with ribosomes and GTP, a 
fluorescence, typical of fADP-ribosylated EF-2, is 
observed in the resuspended ribosome pellet. Ex- 
periments aiming to clarify the structural aspects 
of the complex of the eADP-ribosylated EF-2 with 
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